bims-cytox1 Biomed News
on Cytochrome oxidase subunit 1
Issue of 2026–11–15
five papers selected by
Gavin McStay, Liverpool John Moores University



  1. J Biol Chem. 2026 Nov 12. pii: S0021-9258(26)02614-1. [Epub ahead of print] 113742
      Differentiation of skeletal muscle is associated with increased mitochondrial biogenesis and reliance on oxidative phosphorylation (OXPHOS). The terminal enzyme complex in the electron transport chain, cytochrome c oxidase (COX), requires copper for its assembly and activity, and copper delivery to mitochondria is essential for OXPHOS. However, when mitochondrial copper becomes essential during skeletal myoblast differentiation is not known. Here, we show that inducing genetic deficiency of the mitochondrial copper and phosphate carrier SLC25A3 prior to myoblast differentiation leads to the formation of smaller myotubes, but SLC25A3 deficiency induced in mature myotubes leads to cell death and detachment. Both phenotypes are recapitulated upon genetic knockdown of COX17, a key chaperone for COX copper cofactor assembly, and by chemical inhibition of COX. Importantly, myotube death caused by SLC25A3 deficiency is reversed by copper supplementation. Expression of an SLC25A3 isoform A variant that is equivalent to a variant in isoform B that exclusively transports copper also rescues myotube viability. Taken together these data support a model wherein SLC25A3 is critical for survival in mature myotubes, likely due to its role in providing copper to COX.
    Keywords:  copper; copper transport; cytochrome c oxidase (Complex IV); myogenesis; skeletal muscle
    DOI:  https://doi.org/10.1016/j.jbc.2026.113742
  2. Nitric Oxide. 2026 Nov 13. pii: S1089-8603(26)00176-X. [Epub ahead of print]
      Nitrite can be reduced to nitric oxide (NO) by several heme- and molybdenum-containing proteins, including mitochondrial cytochrome c oxidase (Cco). This activity, designated Cco/NO, has been implicated in hypoxic signaling, but its regulation and quantitative significance relative to other NO-producing systems remain uncertain. We examined its modulation by adenine nucleotides using detergent-solubilized yeast and mouse brain mitochondria supplied with 1 mM nitrite and an ascorbate/TMPD/cytochrome c electron-donor system. ADP and ATP differentially modulated Cco/NO activity, and ADP shifted the apparent oxygen sensitivity of Cco/NO toward lower O2, with the largest stimulation at 10 μM O2 and below (oxygen dependence of the rate different from the nucleotide-free control, p = 0.004; p = 0.027 with the experimental day as the unit of analysis). Nucleotide regulation was also isoform-dependent: ATP slightly inhibited Va-containing Cco but strongly stimulated Vb-containing Cco under anoxic conditions. Rates normalized to cytochrome aa3 demonstrate multi-turnover nitrite-reductase capacity under these substrate-driven assay conditions. Both the cellular ADP/ATP ratio and subsequently assayed Cco/NO activity increased transiently following a hypoxic shift. These findings establish metabolic and isoform-dependent gating of the catalytic capacity of Cco/NO; they do not establish its fractional contribution to total cellular NO or its operation at physiological nitrite concentrations in intact, coupled mitochondria.
    Keywords:  Allosteric regulation; Cytochrome c oxidase isoforms; Hypoxia; Nitrite; Nitrite reductase; Oxygen sensing
    DOI:  https://doi.org/10.1016/j.niox.2026.11.001
  3. Cells. 2026 Oct 25. pii: 1941. [Epub ahead of print]15(21):
      Mitochondrial dysfunction contributes to Alzheimer's disease (AD), but the roles of individual respiratory-chain proteins remain incompletely understood. We examined mitochondrially encoded cytochrome c oxidase subunit II (MT-CO2) and nuclear encoded succinate dehydrogenase complex iron-sulfur subunit B (SDHB) in postmortem temporal cortex from cognitively normal (CN) individuals and patients with AD, Lewy body dementia/Parkinson's disease (LBD/PD), or progressive supranuclear palsy (PSP). MT-CO2 abundance was lower in AD than in CN and LBD/PD, whereas SDHB was lower in AD than in CN, LBD/PD, and PSP. A significant protein × diagnosis interaction indicated distinct diagnostic-group patterns for MT-CO2 and SDHB. In BE(2)-C neuroblastoma cells, repeated 650 nm red-light and 808 nm near-infrared (NIR) photobiomodulation increased MT-CO2 abundance, with the largest responses following 10- and 15-min exposures. shRNA-mediated MT-CO2 reduction impaired Complex IV-dependent respiration and attenuated the bioenergetic response to 808 nm treatment. Photobiomodulation did not significantly alter mitochondrially encoded MT-CO1 or MT-CO3 abundance. These findings identify alterations in MT-CO2 and SDHB in AD temporal cortex and demonstrate that MT-CO2 contributes to Complex IV-dependent respiration and photobiomodulation-associated bioenergetic enhancement. Because mitochondrial content was not independently measured, the tissue findings cannot distinguish broader mitochondrial loss from protein-specific dysregulation.
    Keywords:  Alzheimer’s disease; MT-CO2; complex IV; cytochrome c oxidase; mitochondrial bioenergetics; mitochondrial dysfunction; near-infrared light; neurodegeneration; oxidative phosphorylation; photobiomodulation
    DOI:  https://doi.org/10.3390/cells15211941
  4. Yale J Biol Med. 2026 Sep;99(3): 452-465
      Glioblastoma (GBM) is a lethal and treatment-resistant brain tumor characterized by altered energy metabolism and mitochondrial dysfunction. Cytochrome c oxidase subunit 4 isoform 1 (COX4-1), a nuclear-encoded component of complex IV in the electron transport chain, supports oxidative phosphorylation by facilitating electron transfer to oxygen; however, its role in carcinogenesis remains unclear. This study investigated the function of COX4-1 in GBM and its impact on mitochondrial activity and malignant behavior in vitro. COX4-1 expression in GBM cell lines was analyzed using the DepMap database and validated by quantitative real-time polymerase chain reaction. GBM cells were transfected with COX4-1 siRNA. Cell proliferation, migration, and invasion were assessed using viability, wound-healing, and transwell assays, while apoptosis and mitochondrial membrane potential were evaluated by flow cytometry. Mitochondrial function was examined through mitochondrial DNA (mtDNA) copy number, ATP levels, oxygen consumption rate, lactate dehydrogenase activity, and reactive oxygen species production, along with the expression of genes regulating mitochondrial biogenesis and dynamics. COX4-1 was upregulated in GBM cell lines (U-87MG and LN-18). Its silencing suppressed proliferation, migration, and invasion while promoting apoptosis. COX4-1 knockdown also reduced mtDNA copy number, ATP production, and oxygen consumption rate, and increased reactive oxygen species, lactate dehydrogenase activity, and membrane depolarization, thereby indicating impaired mitochondrial respiratory capacity. Additionally, COX4-1 depletion downregulated biogenesis (PGC-1α, NRF1, NRF2, TFAM) and fusion (MFN1, OPA1) regulators while upregulating the fission gene DRP1. Overall, COX4-1 depletion disrupts mitochondrial integrity and bioenergetics, leading to metabolic collapse and reduced malignancy, thereby representing a promising target for mitochondria-based therapeutic strategies in GBM.
    Keywords:  COX4-1; Glioblastoma; Invasion; Migration; Proliferation; mitochondrial function; mitochondrial metabolism
    DOI:  https://doi.org/10.59249/MWVA3688
  5. Cytotechnology. 2026 Dec;78(6): 233
      Hypoxic-ischemic encephalopathy (HIE) is characterized by mitochondrial dysfunction, excessive oxidative stress, and neuronal apoptosis. Cytochrome c oxidase subunit I (COX1), the catalytic core subunit of mitochondrial complex IV, is particularly susceptible to reactive oxygen species-mediated damage and may influence neuronal survival under hypoxic-ischemic conditions. However, the role of COX1 in HIE and its underlying mechanisms remain unclear. HIE related genes were screened by intergrating data from the GEOGSE144456 and GSE112137 dataset​s . An oxygen-glucose deprivation (OGD) injury model was established in HT22 cells. COX1 expression was quantified using reverse transcription-quantitative polymerase chain reaction (RT-qPCR) and western blotting. Cell viability, proliferation, and apoptosis were assessed using Cell Counting Kit-8 (CCK-8) assays, 5-ethynyl-2'-deoxyuridine (EdU) assays, and annexin V/propidium iodide flow cytometry, respectively. Bioinformatic analysis identified COX1 as a candidate HIE-related target. OGD markedly reduced COX1 expression in HT22 cells. COX1 overexpression increased cell viability and proliferation, reduced apoptosis and cleaved caspase-3 expression, decreased reactive oxygen species (ROS) and malondialdehyde (MDA) levels, increased glutathione (GSH) content and superoxide dismutase (SOD) activity, and upregulated nuclear factor-erythroid 2-related factor 2 (Nrf2) and heme oxygenase-1 (HO-1) expression. These effects were attenuated by the Nrf2 inhibitor ML385. COX1 may protect against oxygen-glucose deprivation-induced neuronal injury by activating the Nrf2/HO-1 pathway, reducing oxidative stress, and suppressing apoptosis.
    Supplementary Information: The online version contains supplementary material available at https://doi.org/10.1007/s10616-026-01105-5.
    Keywords:  Apoptosis; COX1; HT22 cells; Nrf2/HO-1 pathway; OGD; Oxidative stress
    DOI:  https://doi.org/10.1007/s10616-026-01105-5